Skip to main content
Toxicology Research logoLink to Toxicology Research
. 2022 Jan 15;11(1):179–183. doi: 10.1093/toxres/tfab124

Are Ayurvedic medications store house of heavy metals?

A Bhalla 1, A K Pannu 2,
PMCID: PMC8882783  PMID: 35237422

Abstract

Ayurvedic formulations are widely used and perceived as safer medicine and subjected to be self-prescribed. However, recent reports have demonstrated adulterating these drugs with toxic quantities of heavy metals. To study the magnitude of the problem in Indian-manufactured Ayurvedic medications, we randomly collected common over-the-counter Ayurvedic preparations from the licensed Ayurvedic shops in the local markets of Chandigarh in 2017. The samples were analyzed to identify and quantify eight metal ions, including mercury, arsenic, lead, cadmium, zinc, iron, copper, and chromium, using inductively coupled plasma mass spectrometry in Postgraduate Institute of Medical Education and Research, Chandigarh. The permissible limit set by the Food and Agriculture Organization/World Health Organization (FAO/WHO) for herbal medicines was followed to define the high metal concentrations. Out of 43 Ayurvedic preparations, 42 were analyzed. Heavy metals were detected in all formulations. The median (range) concentrations (in μg/g or mg/kg) of the metals were quantified as follows- mercury, 13.52 (0.00–61 095.99); arsenic, 0.00 (0.00–1038.83); lead, 1.40 (0.00–57.09); zinc, 84.2200 (26.48–22 519.03); iron, 1356.21 (128.24–136 835.25); copper, 17.1450 (0.00–12 756.86) and chromium, 20.9050 (0.00–2717.58). The metal contents above the FAO/WHO-mandated limit for zinc, mercury, arsenic, and lead were detected in 35, 29, 6, and 2 formulations, respectively. All medications contained detectable quantities of zinc and iron. Copper was detected in all except one. Cadmium was not found in any sample. Ayurvedic medications have a high prevalence of heavy metals. An evaluation of the sources of contamination and the necessary drug safety regulations are required.

Keywords: Ayurvedic, metals, herbal, toxicity, lead, arsenic, mercury, zinc

Introduction

Ayurvedic medicines are widely used, and over the past decades, their popularity has surprisingly been on the rise, with an estimated global market of ~5000 million US dollars per year [1]. These medications primarily comprise herbal (derived from natural plants), metallic preparations, and animal products. Worldwide, Ayurvedic medicine is principally referred to as complementary and alternative medicine and is mainly used when conventional medicine has limited or no efficacy or causes significant adverse effects [1]. In the low-middle income countries (LMIC), it is also used as a cheaper alternative to conventional medicine. Because of their “natural” origin and use for a long time, Ayurvedic medicine is perceived as safer medicine and subjected to be self-prescribed. Moreover, herbal preparations usually do not undergo the same rigorous testing as conventional medicine and are not evaluated for safety and effectiveness by the US Food and Drug Administration [2, 3]. Therefore, following the dictum “absence of evidence is not evidence of absence,” the adverse effects and pharmacokinetic interactions of herbal medicine might be underreported rather than uncommon.

Trace minerals such as zinc, gold, silver, iron, copper, magnesium, manganese, and chromium are required to carry out specific biochemical reactions in the human body; however, they can exert toxic effects at high levels of exposure. Heavy metals such as lead, arsenic, mercury, and cadmium are xenobiotics and may cause toxicity even at low-level exposure [4–6]. Because the metals (bhasmas) are emphasized as essential for the proper biological functions in rasa shastra Ayurveda; they are added intentionally after “purification” (shodhana) in the formulations [7]. However, many recent reports have demonstrated adulterating herbal medicines with toxic quantities of heavy metals [8–10]. Besides the manufacturing processes (i.e. the addition or mixing of metals), the potential sources of toxicity remain environmental, i.e. conditions in which the herbs are grown, collected, dried, stored, or transported [2–5]. Heavy metals are considered the major environmental pollutants because of massive environmental contamination due to industrialization or urbanization and their toxicity, intrinsic stability, and bioaccumulation nature [11, 12]. The increasing prevalence of heavy metals in herbal preparations might be attributed to heavy metal pollution [13, 14].

Though Ayurveda has been practiced for more than 5000 years in India, Indian studies documenting the prevalence of metals in Ayurvedic pharmaceuticals are limited [7, 15, 16]. This study aims to determine the prevalence of heavy metals in common over-the-counter Ayurvedic medications in Chandigarh, an urban city in north India.

Material and methods

The commonly used Ayurvedic medications were collected from the licensed Ayurvedic shops in the local markets of Chandigarh (India) in 2017. The selection was random and based on high selling and popularity among the local public, including the various categories according to their actions or indications. We tried to obtain at least two medications of the same class (indication) to preserve the assumption of independence of observations. Samples were stored in pharmacy plastic bags and labeled with a numerical identification to make the laboratory team blind for the sample identity.

The samples were processed in the laboratory of the Department of Pediatric Biochemistry, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research, Chandigarh, a large academic medical institute in north India. The analysis was performed to identify and quantify eight metal ions, including mercury, arsenic, lead, cadmium, zinc, iron, copper, and chromium, using inductively coupled plasma mass spectrometry with Agilent Technologies 7700 series instrument (Agilent 7700 ICP-MS™). For microwave digestion, 10 μg of the sample was weighed into a digestion vessel, followed by the addition of 2 ml of concentrated nitric acid, 0.5 ml of hydrogen peroxide and 10 ppm of gold solution. All quality control, assurance, and safety measures were adequately undertaken.

The concentration of heavy metals was expressed in units of mg/kg or μg/g (ppm). The permissible limit set by the Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO) for herbal medicines was followed, i.e. 10 μg/g for arsenic and lead, 1 μg/g for mercury, 0.3 μg/g for cadmium, and 50 μg/g for zinc [17]. The permissible limit for lead, mercury, and cadmium is the same mandated by Indian guidelines from the Department of Ayurveda, Unani, Siddha, and Homeopathy (AYUSH); however, a lower limit is set for arsenic (3 μg/g) [18]. The regulatory limit of FAO/WHO or AYUSH for iron, copper, magnesium, and chromium in medicinal herbs has not been established yet [17, 18].

For analysis, the data were fed in Microsoft Excel 2007. The discrete data were recorded as frequency (n) or percentage (%), and continuous data as median with range.

Results

A total of 43 Ayurvedic formulations were randomly selected. Indications of the medications and the metals (Bhasma) mentioned on the label are summarized in Table 1. Rejuvenation tonics and anti-inflammatory were the common categories (n = 7, each). However, only 8 of 43 had a single indication, and the majority could be used in several common conditions. Out of 42, 13 were a single ingredient, two had two components, and the rest (n = 28) had three or more (up to 30). All medications were prescribed twice or thrice daily doses for weeks or months to the users. 27.9% (n = 12) Ayurvedic formulations had listed heavy metals on the label, including seven had single metal, two had two metals, and two had three metals (Table 1).

Table 1.

Ayurvedic pharmaceuticals (n = 43) with their action or indication of use, the number of collected samples and heavy metal listed on the label

SN Indication/action n Metals listed
1 Rejuvenator tonic 7 Zinc (n = 2), gold (n = 2), silver (n = 2), tin (n = 1), magnesium (n = 1)
2 Anti-inflammatory for joint disease 7 Mercury (n = 1)
3 Aphrodisiac 5
4 Digestive system abnormality 4
5 Liver dysfunction 3 Manganese (n = 1), mica (n = 1), copper (n = 1), iron (n = 1), mercury (n = 1)
6 Hemorrhoids 3
7 Immunomodulator 3
8 Menstrual problem 3 Iron (n = 1)
9 Anti-diabetic 2
10 Nervous system abnormality 2 Mercury (n = 1)
11 Anti-obesity 2 Mica (n = 1)
12 Renal stone disease 2

Forty-two samples were analyzed, and one was excluded due to technical difficulties. The prevalence of heavy metals in the Ayurvedic formulations tested in this study is shown in Table 2 (and Supplementary Table 1). All medications contained detectable quantities of zinc and iron. Copper was detected in all except one. Cadmium was not found in any product. All except one preparation had at least one metal with a concentration higher than FAO/WHO permissible limit, most prevalent being zinc (n = 35) and mercury (n = 29). About 73.8% formulations contained above-limit levels of mercury, arsenic, or lead.

Table 2.

Prevalence of the heavy metals in the Ayurvedic medications (n = 42)

SN Heavy metals Median (range) ppm (μg/g) or (mg/kg) Values (n) higher than permissible limita Undetectable (0.00) level
1 Mercury 13.52 (0.00–61 095.99) 29 13
2 Arsenic 0.00 (0.00–1038.83) 6 36
3 Lead 1.40 (0.00–57.09) 2 8
4 Zinc 84.2200 (26.48–22 519.03) 35 0
5 Iron 1356.21 (128.24–136 835.25) NA 0
6 Copper 17.1450 (0.00–12 756.86) NA 1
7 Chromium 20.9050 (0.00–2717.58) NA 4
8 Cadmium 0.00 (0.00–0.00) 0 42

aThe permissible limit set by the FAO/WHO for herbal medicines was followed, i.e. 10 μg/g for arsenic and lead, 1 μg/g for mercury, 0.3 μg/g for cadmium, and 50 μg/g for zinc. The permissible limit for iron, copper, magnesium, and chromium in medicinal herbs has not been established yet. NA: not applicable.

Discussion

Our study found a high prevalence of heavy metals in a random sample of commonly used Ayurvedic medicines in north India. We detected heavy metals in all formulations, although only 28% of Ayurvedic products had listed metals on their labels. The metal concentrations above the FAO/WHO and AYUSH-mandated limit for zinc, mercury, and/or arsenic are seen in all except one formulation. Detectable levels of zinc, iron, copper, and chromium were almost universally present. Cadmium was not detected in any sample.

Metals after purification in the rasa shastra are considered therapeutic without adverse effects. The high prevalence and toxic concentrations of heavy metals in our report and similar studies might have resulted from environmental contaminations of the herbal plants (e.g. heavy metal pollution) or manufacturing processes with incidental or intentional mixing of the metals [8–10, 19–22]. Furthermore, Ayurvedic pharmaceuticals are also not closely regulated for safety, and enforcement of related laws is considerably less strict in LMIC than in the developed world [23, 24]. Heavy metals, i.e. lead, arsenic, and mercury rank the top three in the hazardous substance list of the US Agency for Toxic Substances and Disease Registry (ATSDR) [6, 11]. Detectable levels of these metals were prevalent in our samples, supporting the recent worldwide observations [8–10, 20–22].

The lead remained the leading heavy metal detected in Ayurvedic preparations manufactured in the western world, whereas mercury was more frequently reported in Indian-manufactured products, like in this study [9, 10, 15, 16]. At least two out of three formulations had higher than regulatory limits of mercury in our sample. Chronic ingestion of mercury is linked to neurological and renal adverse effects. Although toxic lead contents were relatively less prevalent in our sample than previously reported, it remains the most hazardous toxicant [6, 11]. Much clinical toxicity from Ayurvedic drugs has been attributed to their toxic lead content, affecting multiple organs (e.g. gastrointestinal, hematological, neurological, or cardiovascular system; [8–10, 25–27]). Chronic exposure to arsenic is associated with many conditions, including cancers, reported with herbal drugs [4–6, 25]. Cadmium exposure, listed at sixth place in ATSDR, has been observed after herbal medicine intake. However, it was not detected in our Ayurvedic products. The explanation for the variation of heavy metals concentrations in different origin herbal preparations is not clear; however, variation in the regional heavy metal pollution might play a role [13, 28–31].

All samples contained zinc and iron. These metals are essential trace elements for human physiology; however, chronic ingestion causes many adverse effects. Immune dysfunction and hypo-proliferative anemia may occur with long-term zinc exposure. Chronic iron toxicity can manifest with gastrointestinal upset or increased susceptibility to infections (e.g. malaria, mucormycosis; [32]). Excess zinc has also been linked to mucormycosis [32, 33]. Copper and chromium were prevalent in our formulations. These metals are primarily non-toxic, but higher doses can cause liver, kidney, or brain abnormalities.

Although properly made Ayurvedic medications are believed to be a great boon to humanity, being helpful to prevent and treat various disorders, the potential for toxic metal exposure is increasingly evident. Because our sample formulations were prescribed twice or thrice daily doses for weeks or months, the resultant chronic exposure leads to bioaccumulation. The products contain heavy metals not listed on the label and may have a metal “substitution” (the labeled metal might not even be present). The herbal medicine users may develop undiagnosed or subclinical toxicity. Moreover, many of them do not report the herbal use to the clinicians. Thus, when asking patients about their medication use, clinicians should ask directly about Ayurvedic or herbal medicines and look for the specific signs of metal toxicity. Early recognition and the termination of exposure are essential components of the management of metal toxicity.

Although we had a reasonable sample size with multi-element detection, a single-center observation limits the generalizability of the results. Our study did not address the potential sources of increased toxic heavy metal contents. Because environmental contamination remains an essential factor, as almost every food product has hazardous chemicals (including heavy metals), a large multicenter study with matched control might clarify any contribution of heavy metal pollution.

Conclusion

Our study highlights the concern about the potential heavy metal toxicity of Ayurvedic medications. Heavy metals are prevalent in Indian-manufactured Ayurvedic preparations, and mercury, arsenic, and zinc are typical toxic-metal contents. The nature and amount of the metals may not be recognized by the ingredient listed on the pharmaceutical label. These results call for evaluating the sources of toxic metal concentrations, e.g. environmental contamination (including heavy metal pollution) or manufacturing processes, and the necessary regulations for the safety of Ayurvedic medications.

Supplementary Material

Supplementary_Table_1_tfab124

Acknowledgment

The authors thank Mrs Sunaina Verma for her help with statistics.

Contributor Information

A Bhalla, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, 4th Floor, F Block, Nehru Hospital, PGIMER, Chandigarh 160012, India.

A K Pannu, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, 4th Floor, F Block, Nehru Hospital, PGIMER, Chandigarh 160012, India.

Funding

None declared.

Conflict of interest statement

None declared.

Authors’ contributions

AB: Conceptualization (lead); Data curation; Methodology; Formal analysis (supporting); Writing-original draft (supporting); and Writing-review & editing (supporting).

AKP: Conceptualization (supporting); Formal analysis (lead); Writing-original draft (lead); and Writing-review & editing (lead).

Reference

  • 1. Eisenberg DM, Davis RB, Ettner SLet al. . Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569–75. [DOI] [PubMed] [Google Scholar]
  • 2. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170–8. [DOI] [PubMed] [Google Scholar]
  • 3. Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol 2003;120:127–37. [DOI] [PubMed] [Google Scholar]
  • 4. Dargan PI, Gawarammana IB, Archer JRHet al. . Heavy metal poisoning from Ayurvedic traditional medicines: an emerging problem? Int J Environment and Health 2008;2:463–74. [Google Scholar]
  • 5. Shaban NS, Abdou KA, Hassan NY. Impact of toxic heavy metals and pesticide residues in herbal products. BJBAS 2016;5:102–6. [Google Scholar]
  • 6. Howard H. Heavy metal poisoning. In: Jameson JL, Kasper DL, Longo DLet al. (eds). Harrison’s Principles of Internal Medicine, 19th edn. New York, NY: McGraw- Hill Education, 2018, 3297–300. [Google Scholar]
  • 7. Kumar G, Gupta YK. Evidence for safety of Ayurvedic herbal, herbo-metallic and Bhasma preparations on neurobehavioral activity and oxidative stress in rats. Ayu 2012;33:569–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Lynch E, Braithwaite R. A review of the clinical and toxicological aspects of 'traditional' (herbal) medicines adulterated with heavy metals. Expert Opin Drug Saf 2005;4:769–78. [DOI] [PubMed] [Google Scholar]
  • 9. Saper RB, Kales SN, Paquin Jet al. . Heavy metal content of ayurvedic herbal medicine products. JAMA 2004;292:2868–73. [DOI] [PubMed] [Google Scholar]
  • 10. Saper RB, Phillips RS, Sehgal Aet al. . Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008;300:915–23Erratum in: JAMA 2008;300(14):1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ATSDR Agency for Toxic Substances and Disease Registry Substance Priority List ; 2019. Available from:https://www.atsdr.cdc.gov/spl/index.html. (3 May 2021, date last accessed).
  • 12. Briffa J, Sinagra E, Blundell R. Heavy metal pollution in the environment and their toxicological effects on humans. Heliyon 2020;6:e04691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Street RA. Heavy metals in medicinal plant products – an African perspective. S Afr J Bot 2012;82:67–74. [Google Scholar]
  • 14. Luo L, Wang B, Jiang Jet al. . Heavy metal contaminations in herbal medicines: determination, comprehensive risk assessments, and solutions. Front Pharmacol 2021;11:595335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kumar G, Gupta YK. Monitoring of mercury, arsenic, cadmium and lead in Ayurvedic formulations marketed in Delhi by flame AAS and confirmation by ICP-MS. Food Addit Contam Part B Surveill 2012;5:140–4. [DOI] [PubMed] [Google Scholar]
  • 16. Sen I, Pendam BV. Determination of heavy metals in five major ingredients of herbal medicines. IJPSR 2014;5:4310–4. [Google Scholar]
  • 17. World Health Organization . WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: WHO, 2007. Available from:https://apps.who.int/iris/bitstream/handle/10665/43510/9789241594448_eng.pdf?sequence=1&isAllowed=y. (3 May 2021, date last accessed). [Google Scholar]
  • 18. Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India . General Guidelines for Drug Development of Ayurvedic Formulations. New Delhi: Ministry of AYUSH, Government of India, 2018. Available from:https://www.ayush.gov.in/docs/guideline-drug-development.pdf. (16 November 2020, date last accessed. [Google Scholar]
  • 19. Shah WA, Zakiullah KF, Khuda Fet al. . Comparison of toxic heavy metals concentration in medicinal plants and their respective branded herbal formulations commonly available in Khyber Pakhtunkhwa. Pak J Pharm Sci 2016;29:1251–6. [PubMed] [Google Scholar]
  • 20. Nkansah MA, Korankye M, Darko G, et al. Heavy metal content and potential health risk of geophagic white clay from the Kumasi metropolis in Ghana. Toxicol Rep 2016;3:644–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Bakar MA, Bhattacherjy SC. Assessment of heavy metals concentration in some selected medicinal plants Collected from BCSIR, Chittagong cultivation area in Bangladesh. Hamdard Medicus 2012;55:26–32. [Google Scholar]
  • 22. Dghaim R, al Khatib S, Rasool H, et al. . Determination of heavy metals concentration in traditional herbs commonly consumed in the United Arab Emirates. J Environ Public Health 2015;2015:1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Nkeiruka IZ, Ebere OO, Obianime AW. Nigerian herbal remedies and heavy metals violation of standard recommended guidelines. Asian Pac J Trop Biomed 2012;2012:S1423–30. [Google Scholar]
  • 24. Abualhasan M, Jaradat N, Sawaftah Zet al. . Evaluation of heavy metals and microbiological contamination of selected herbals from Palestine. Open Life Sci 2019;14:448–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Pierce JM, Estrada CA, Mathews RE Jr. Buyers beware: lead poisoning due to Ayurvedic medicine. J Gen Intern Med 2012;27:1384–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Breeher L, Mikulski MA, Czeczok Tet al. . A cluster of lead poisoning among consumers of Ayurvedic medicine. Int J Occup Environ Health 2015;21:303–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Mikulski MA, Wichman MD, Simmons DLet al. . Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation. Int J Occup Environ Health 2017;23:187–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Annan K, Dickson RA, Amponsah IK, et al. . The heavy metal contents of some selected medicinal plants sampled from different geographical locations. Pharm Res 2013;5:103–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Khan MS, Javed M, Rehman MTet al. . Heavy metal pollution and risk assessment by the battery of toxicity tests. Sci Rep 2020;10:16593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Abdulla NM, Adam B, Blair I, et al. . Heavy metal content of herbal health supplement products in Dubai - UAE: a cross-sectional study. BMC Complement Altern Med 2019;19:276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Tschinkel PFS, Melo ESP, Pereira HSet al. . The hazardous level of heavy metals in different medicinal plants and their decoctions in water: a public health problem in Brazil. Biomed Res Int 2020;2020:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Bhanuprasad K, Manesh A, Devasagayam Eet al. . Risk factors associated with the Mucormycosis epidemic during the COVID-19 pandemic. Int J Infect Dis 2021;111:267–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Muthu V, Kumar M, Paul RAet al. . Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study. Mycoses 2021;64:1291–7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary_Table_1_tfab124

Articles from Toxicology Research are provided here courtesy of Oxford University Press

RESOURCES